China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
China Resources Pharmaceutical Group Ltd. has increased its stake in CR Boya Bio-pharmaceutical by 1%, raising its indirect ownership to approximately 30.28%. This move reflects the company’s confidence in CR Boya’s growth potential and aims to bolster investor confidence. The group plans to further increase its shareholding by up to 1.2% over the next six months, signaling a strong commitment to its subsidiary’s continued development.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
